Join the club for FREE to access the whole archive and other member benefits.

Katy Rezvani

Chief of Section of Cellular Therapy in Dept of Stem Cell Transplantation & Cellular Therapy at MD Anderson Cancer Center

Dr. Katy Rezvani is a Professor of Stem Cell Transplantation & Cellular Therapy at The University of Texas MD Anderson Cancer Center, where she serves as the Sally Cooper Murray Chair in Cancer Research, chief of the section for cellular therapy, director of translational research, and medical director of the GMP Facility. She also serves as executive director of MD Anderson's Adoptive Cell Therapy Platform. She leads a research lab with a focus on NK cell biology and developing novel NK cell engineering strategies for cancer, with the aim of translating these discoveries to the clinic. Dr. Rezvani completed her medical training at University College London, England and her PhD at Imperial College London. She completed her training in immunology and transplantation biology at the National Institutes of Health, Bethesda, MD. In addition, she has co-authored over 200 peer-reviewed publications and has received multiple prizes and awards.

Visit website: https://faculty.mdanderson.org/profiles/katy_rezvani.html

 katy-rezvani-64474914

 lab_rezvani

See also: Academia MD Anderson Cancer Center - Comprehensive cancer center in Houston, Texas

Details last updated 28-Jul-2024

Katy Rezvani is also referenced in the following:

Bit.bio

Human cell coding company